142 related articles for article (PubMed ID: 9577332)
1. Octreotide in hepatocellular carcinoma.
Shouval D
Gut; 1998 Mar; 42(3):316-7. PubMed ID: 9577332
[No Abstract] [Full Text] [Related]
2. [Somatostatin analogue (octreotide)].
Sano K; Makuuchi M
Nihon Rinsho; 2001 Oct; 59 Suppl 6():674-7. PubMed ID: 11762035
[No Abstract] [Full Text] [Related]
3. Somatostatin analogs and hepatocellular carcinoma: Not dead yet?
Raftery L; O'Neil BH
Cancer Biol Ther; 2009 Nov; 8(21):2040-1. PubMed ID: 19823044
[No Abstract] [Full Text] [Related]
4. Somatostatin and hepatocellular carcinoma.
Kapadia CR
Gastroenterology; 1998 Nov; 115(5):1298-9. PubMed ID: 9797392
[No Abstract] [Full Text] [Related]
5. Treatment of hepatocellular carcinoma with octreotide: a randomised controlled study.
Kouroumalis E; Skordilis P; Thermos K; Vasilaki A; Moschandrea J; Manousos ON
Gut; 1998 Mar; 42(3):442-7. PubMed ID: 9577356
[TBL] [Abstract][Full Text] [Related]
6. Octreotide and hepatocellular carcinoma.
Farinati F; Sergio A; Baldan A; Zucchetta P; Corleto VD
Br J Cancer; 2007 Jun; 96(11):1778-9. PubMed ID: 17505506
[No Abstract] [Full Text] [Related]
7. [A therapeutic study of hepatocellular carcinoma using octreotide (HECTOR). Hepatocellular Carcinoma: Treatment with Octreotide].
Allgaier HP; Becker G; Blum HE
Dtsch Med Wochenschr; 2000 Mar; 125(11):320. PubMed ID: 10761474
[No Abstract] [Full Text] [Related]
8. Octreotide treatment of hepatocellular carcinoma.
Kouroumalis E; Samonakis D; Skordilis P
Hepatology; 2003 Feb; 37(2):477. PubMed ID: 12540801
[No Abstract] [Full Text] [Related]
9. Complete, long-standing regression of hepatocellular carcinoma after somatostatin analogue treatment.
Rahmi G; Malka D; Tomasic G; Dromain C; Ducreux M; Boige V
J Clin Oncol; 2007 Jun; 25(16):e15-6. PubMed ID: 17538153
[No Abstract] [Full Text] [Related]
10. Complete regression of advanced HCC with long acting octreotide.
Siveke JT; Herberhold C; Folwaczny C
Gut; 2003 Oct; 52(10):1531. PubMed ID: 12970151
[No Abstract] [Full Text] [Related]
11. Octreotide for unresectable hepatocellular carcinoma: beyond the first sight.
Samonakis DN; Christodoulakis N; Kouroumalis EA
J Clin Gastroenterol; 2006 Jan; 40(1):86-7. PubMed ID: 16340641
[No Abstract] [Full Text] [Related]
12. Octreotide inhibits the growth and development of three types of experimental liver metastasis.
Frizelle FA
Br J Surg; 1995 Nov; 82(11):1577. PubMed ID: 8535822
[No Abstract] [Full Text] [Related]
13. The role of somatostatin analogs in the management of hepatocellular carcinoma.
D'Agostino L; Manguso F; Pivonello R; Colao A
J Endocrinol Invest; 2003; 26(8 Suppl):131-3. PubMed ID: 15233229
[No Abstract] [Full Text] [Related]
14. Treatment of Advanced Hepatocellular Carcinoma with Somatostatin Analogues: A Review of the Literature.
Reynaert H; Colle I
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31569719
[TBL] [Abstract][Full Text] [Related]
15. Somatostatin receptor expression in hepatocellular carcinoma: prognostic and therapeutic considerations.
Abdel-Rahman O; Lamarca A; Valle JW; Hubner RA
Endocr Relat Cancer; 2014; 21(6):R485-93. PubMed ID: 25336571
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin receptor expression, tumour response, and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotide.
Cebon J; Findlay M; Hargreaves C; Stockler M; Thompson P; Boyer M; Roberts S; Poon A; Scott AM; Kalff V; Garas G; Dowling A; Crawford D; Ring J; Basser R; Strickland A; Macdonald G; Green M; Nowak A; Dickman B; Dhillon H; Gebski V;
Br J Cancer; 2006 Oct; 95(7):853-61. PubMed ID: 16953241
[TBL] [Abstract][Full Text] [Related]
17. The tumour vanishes.
Todd JF; Meeran K
Clin Endocrinol (Oxf); 2000 Dec; 53(6):663-4. PubMed ID: 11155085
[No Abstract] [Full Text] [Related]
18. Somatostatin analogues in advanced hepatocellular carcinoma: an updated systematic review and meta-analysis of randomized controlled trials.
Ji XQ; Ruan XJ; Chen H; Chen G; Li SY; Yu B
Med Sci Monit; 2011 Aug; 17(8):RA169-176. PubMed ID: 21804474
[TBL] [Abstract][Full Text] [Related]
19. Systemic treatment of hepatocellular carcinoma.
Treiber G
Dig Dis; 2001; 19(4):311-23. PubMed ID: 11935091
[TBL] [Abstract][Full Text] [Related]
20. Use of the somatostatin analogue octreotide to localise and manage somatostatin-producing tumours.
Angeletti S; Corleto VD; Schillaci O; Marignani M; Annibale B; Moretti A; Silecchia G; Scopinaro F; Basso N; Bordi C; Delle Fave G
Gut; 1998 Jun; 42(6):792-4. PubMed ID: 9691916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
